Organelle-Partitioned Sugar–Rhodamine Diad for In Vivo Tumor Imaging
Author(s) -
Enkang Zhang,
Chaozhang Yu,
Hui Tang,
Yuntong Li,
Dongliang Zuo,
Rongshui Yang,
Chao Ma,
Jiayin Miao,
Pingguo Liu,
Xinhui Su
Publication year - 2020
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.0c02323
Subject(s) - sialic acid , organelle , lysosome , in vivo , fluorescence , chemistry , cell sorting , rhodamine , rhodamine 123 , cell , biochemistry , biophysics , microbiology and biotechnology , cancer research , biology , physics , quantum mechanics , multiple drug resistance , enzyme , antibiotics
Current tumor imaging agents are often limited by their liability to dissipate from tumor tissues. As cell sugar sorting enables exogenous sugars to be delivered into predetermined subcellular locations, we synthesized sialic acid (Sia) derivatives with rhodamine-X conjugated at C-9 ( ROX Sia), which hitchhikes cell sialic acid sorting to target tumor cell lysosomes, exhibiting pH-independent long-term probe retention in lysosomes. ROX Sia gives selective, bright, and endured fluorescence signals in subcutaneous tumors and orthotopic tumors in mice models. These results indicate the potential of ROX Sia as a lysosome-targeted optical agent for fluorescence-guided tumor resection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom